메뉴 건너뛰기




Volumn 57, Issue 8, 2013, Pages 3681-3687

High-throughput screening of a collection of known pharmacologically active small compounds for identification of candida albicans biofilm inhibitors

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AURANOFIN; AVERMECTIN B1 A; BENZBROMARONE; BIFONAZOLE; BUTENAFINE; BUTOCONAZOLE; CICLOPIROXOLAMINE; CLOTRIMAZOLE; ECONAZOLE; ENILCONAZOLE; FLUCONAZOLE; FLUCYTOSINE; ISOCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; NYSTATIN; OXICONAZOLE; PYRVINIUM EMBONATE; SERTACONAZOLE; SULCONAZOLE; TERCONAZOLE; TIOCONAZOLE; UNINDEXED DRUG; VORICONAZOLE; YOHIMBINE; ZOTEPINE;

EID: 84880275318     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00680-13     Document Type: Article
Times cited : (97)

References (43)
  • 3
    • 0036228505 scopus 로고    scopus 로고
    • Biofilms: Survival mechanisms of clinically relevant microorganisms
    • Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
    • (2002) Clin. Microbiol. Rev. , vol.15 , pp. 167-193
    • Donlan, R.M.1    Costerton, J.W.2
  • 4
    • 0037230342 scopus 로고    scopus 로고
    • Candida biofilms and their role in infection
    • Douglas LJ. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11:30-36.
    • (2003) Trends Microbiol. , vol.11 , pp. 30-36
    • Douglas, L.J.1
  • 6
    • 33749986341 scopus 로고    scopus 로고
    • Candida biofilms on implanted biomaterials: A clinically significant problem
    • Ramage G, Martinez JP, Lopez-Ribot JL. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6:979-986.
    • (2006) FEMS Yeast Res. , vol.6 , pp. 979-986
    • Ramage, G.1    Martinez, J.P.2    Lopez-Ribot, J.L.3
  • 8
    • 0034863427 scopus 로고    scopus 로고
    • Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms
    • Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479.
    • (2001) Antimicrob. Agents Chemother. , vol.45 , pp. 2475-2479
    • Ramage, G.1    Vande Walle, K.2    Wickes, B.L.3    Lopez-Ribot, J.L.4
  • 10
    • 0035431077 scopus 로고    scopus 로고
    • Biofilms of Candida albicans and their associated resistance to antifungal agents
    • Ramage G, Wickes BL, Lopez-Ribot JL. 2001. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am. Clin. Lab. 20:42-44.
    • (2001) Am. Clin. Lab. , vol.20 , pp. 42-44
    • Ramage, G.1    Wickes, B.L.2    Lopez-Ribot, J.L.3
  • 11
    • 0036096359 scopus 로고    scopus 로고
    • Antifungal susceptibility of Candida biofilms: Unique efficacy of amphotericin B lipid formulations and echinocandins
    • Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob. Agents Chemother. 46:1773-1780.
    • (2002) Antimicrob. Agents Chemother. , vol.46 , pp. 1773-1780
    • Kuhn, D.M.1    George, T.2    Chandra, J.3    Mukherjee, P.K.4    Ghannoum, M.A.5
  • 12
    • 67650407551 scopus 로고    scopus 로고
    • Outcome of antimicrobial therapy in documented biofilm-associated infections: A review of the available clinical evidence
    • Falagas ME, Kapaskelis AM, Kouranos VD, Kakisi OK, Athanassa Z, Karageorgopoulos DE. 2009. Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence. Drugs 69:1351-1361.
    • (2009) Drugs , vol.69 , pp. 1351-1361
    • Falagas, M.E.1    Kapaskelis, A.M.2    Kouranos, V.D.3    Kakisi, O.K.4    Athanassa, Z.5    Karageorgopoulos, D.E.6
  • 13
    • 84855683118 scopus 로고    scopus 로고
    • Antifungal resistance and new strategies to control fungal infections
    • Vandeputte P, Ferrari S, Coste AT. 2012. Antifungal resistance and new strategies to control fungal infections. Int. J. Microbiol. 2012:1-26.
    • (2012) Int. J. Microbiol. , vol.2012 , pp. 1-26
    • Vandeputte, P.1    Ferrari, S.2    Coste, A.T.3
  • 15
    • 77954340744 scopus 로고    scopus 로고
    • FDA regulations for drug development
    • doi:10.1126/science.329.5987.33-b
    • Behrman RE, Woodcock J. 2010. FDA regulations for drug development. Science 329:33. doi:10.1126/science.329.5987.33-b.
    • (2010) Science , vol.329 , pp. 33
    • Behrman, R.E.1    Woodcock, J.2
  • 16
    • 0021742042 scopus 로고
    • Isolation of the Candida albicans gene for orotidine-5=-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations
    • Gillum AM, Tsay EY, Kirsch DR. 1984. Isolation of the Candida albicans gene for orotidine-5=-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol. Gen. Genet. 198:179-182.
    • (1984) Mol. Gen. Genet. , vol.198 , pp. 179-182
    • Gillum, A.M.1    Tsay, E.Y.2    Kirsch, D.R.3
  • 17
    • 51649130981 scopus 로고    scopus 로고
    • A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing
    • Pierce CG, Uppuluri P, Tristan AR, Wormley FL, Jr, Mowat E, Ramage G, Lopez-Ribot JL. 2008. A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat. Protoc. 3:1494-1500.
    • (2008) Nat. Protoc. , vol.3 , pp. 1494-1500
    • Pierce, C.G.1    Uppuluri, P.2    Tristan, A.R.3    Wormley Jr., F.L.4    Mowat, E.5    Ramage, G.6    Lopez-Ribot, J.L.7
  • 18
    • 60649094307 scopus 로고    scopus 로고
    • Effect of tunicamycin on Candida albicans biofilm formation and maintenance
    • Pierce CG, Thomas DP, Lopez-Ribot JL. 2009. Effect of tunicamycin on Candida albicans biofilm formation and maintenance. J. Antimicrob. Chemother. 63:473-479.
    • (2009) J. Antimicrob. Chemother. , vol.63 , pp. 473-479
    • Pierce, C.G.1    Thomas, D.P.2    Lopez-Ribot, J.L.3
  • 21
    • 0023760272 scopus 로고
    • Overview of medically important antifungal azole derivatives
    • Fromtling RA. 1988. Overview of medically important antifungal azole derivatives. Clin. Microbiol. Rev. 1:187-217.
    • (1988) Clin. Microbiol. Rev. , vol.1 , pp. 187-217
    • Fromtling, R.A.1
  • 24
    • 77955355113 scopus 로고    scopus 로고
    • Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene
    • Nett JE, Crawford K, Marchillo K, Andes DR. 2010. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob. Agents Chemother. 54:3505-3508.
    • (2010) Antimicrob. Agents Chemother. , vol.54 , pp. 3505-3508
    • Nett, J.E.1    Crawford, K.2    Marchillo, K.3    Andes, D.R.4
  • 25
    • 70350787156 scopus 로고    scopus 로고
    • Amphotericin B and its new derivatives-mode of action
    • Baginski M, Czub J. 2009. Amphotericin B and its new derivatives-mode of action. Curr. Drug Metab. 10:459-469.
    • (2009) Curr. Drug Metab. , vol.10 , pp. 459-469
    • Baginski, M.1    Czub, J.2
  • 29
    • 52949098031 scopus 로고    scopus 로고
    • Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics
    • Zorko M, Jerala R. 2008. Alexidine and chlorhexidine bind to lipopolysaccharide and lipoteichoic acid and prevent cell activation by antibiotics. J. Antimicrob. Chemother. 62:730-737.
    • (2008) J. Antimicrob. Chemother. , vol.62 , pp. 730-737
    • Zorko, M.1    Jerala, R.2
  • 30
    • 0022372175 scopus 로고
    • Final report on the safety assessment of benzethonium chloride and methylbenzethonium chloride
    • Journal Of Toxicology I
    • International Journal of Toxicology 1985. Final report on the safety assessment of benzethonium chloride and methylbenzethonium chloride. Intl. J. Toxicol. 4:65-106.
    • (1985) Intl. J. Toxicol. , vol.4 , pp. 65-106
  • 31
    • 36749095785 scopus 로고    scopus 로고
    • A review of thimerosal (merthiolate) and its ethylmercury breakdown product: Specific historical considerations regarding safety and effectiveness
    • Geier DA, Sykes LK, Geier MR. 2007. A review of thimerosal (merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J. Toxicol. Environ. Health B Crit. Rev. 10:575-596.
    • (2007) J. Toxicol. Environ. Health B Crit. Rev. , vol.10 , pp. 575-596
    • Geier, D.A.1    Sykes, L.K.2    Geier, M.R.3
  • 34
    • 0038147060 scopus 로고    scopus 로고
    • Gold compound auranofin inhibits IB kinase (IKK) by modifying Cys-179 of IKK subunit
    • Jeon KI, Byun MS, Jue DM. 2003. Gold compound auranofin inhibits IB kinase (IKK) by modifying Cys-179 of IKK subunit. Exp. Mol. Med. 35:61-66.
    • (2003) Exp. Mol. Med. , vol.35 , pp. 61-66
    • Jeon, K.I.1    Byun, M.S.2    Jue, D.M.3
  • 36
    • 28144462450 scopus 로고    scopus 로고
    • Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone
    • Iwanaga T, Kobayashi D, Hirayama M, Maeda T, Tamai I. 2005. Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromarone. Drug Metab. Dispos. 33:1791-1795.
    • (2005) Drug Metab. Dispos. , vol.33 , pp. 1791-1795
    • Iwanaga, T.1    Kobayashi, D.2    Hirayama, M.3    Maeda, T.4    Tamai, I.5
  • 37
    • 2642518851 scopus 로고    scopus 로고
    • Quantitative binding models for CYP2C9 based on benzbromarone analogues
    • Locuson CW, II, Rock DA, Jones JP. 2004. Quantitative binding models for CYP2C9 based on benzbromarone analogues. Biochemistry 43:6948-6958.
    • (2004) Biochemistry , vol.43 , pp. 6948-6958
    • Locuson, C.W.1    Rock, D.A.2    Jones, J.P.3
  • 38
    • 0017342373 scopus 로고
    • Anthelmintics
    • Katz M. 1977. Anthelmintics. Drugs 13:124-136.
    • (1977) Drugs , vol.13 , pp. 124-136
    • Katz, M.1
  • 39
    • 80053460614 scopus 로고
    • The effectiveness of two anthelmintics, Vermox (mebendazole) and Povan (pyrvinium pamoate), on Thelastomatid nematodes (Nematoda: Oxyuroidea) of the cockroach, Gromphadorhina portentosa
    • Yu X, Crites JL. 1990. The effectiveness of two anthelmintics, Vermox (mebendazole) and Povan (pyrvinium pamoate), on Thelastomatid nematodes (Nematoda: Oxyuroidea) of the cockroach, Gromphadorhina portentosa. Ohio J. Sci. 90:152-155.
    • (1990) Ohio J. Sci. , vol.90 , pp. 152-155
    • Yu, X.1    Crites, J.L.2
  • 41
    • 0016631074 scopus 로고
    • Mechanisms of anthelmintic action
    • Sheth UK. 1975. Mechanisms of anthelmintic action. Prog. Drug Res. 19:147-157.
    • (1975) Prog. Drug Res. , vol.19 , pp. 147-157
    • Sheth, U.K.1
  • 42
    • 4544229589 scopus 로고    scopus 로고
    • Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5- dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation
    • Esumi H, Lu J, Kurashima Y, Hanaoka T. 2004. Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl) ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation. Cancer Sci. 95:685-690.
    • (2004) Cancer Sci. , vol.95 , pp. 685-690
    • Esumi, H.1    Lu, J.2    Kurashima, Y.3    Hanaoka, T.4
  • 43
    • 0036170245 scopus 로고    scopus 로고
    • Chemotherapeutic approaches to nematodes: Current knowledge and outlook
    • Harder A. 2002. Chemotherapeutic approaches to nematodes: current knowledge and outlook. Parasitol. Res. 88:272-277.
    • (2002) Parasitol. Res. , vol.88 , pp. 272-277
    • Harder, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.